Interobserver variability of histopathological assessment in pT1 colorectal carcinoma
Por:
de Gordoa, KS, Daca-Alvarez, M, Rodrigo-Calvo, M, Archilla, I, Lopez-Prades, S, Aguirre, JJ, Alarcon-Molero, L, Jurado, MC, Canosa, A, Giner, F, González-Lois, C, Jimeno, M, Jurado, I, Machado, I, Martínez-Ciarpaglini, C, Musulen, E, Naranjo, D, Papaleo, N, Peña, C, Rosiñol, O, Sánchez-Yuste, R, Benítez, GTV, Pellisé, M and Cuatrecasas, M
Publicada:
1 mar 2026
Ahead of Print:
1 dic 2025
Resumen:
Aims Pathological evaluation of colorectal carcinoma (CRC) diagnosed at stage pT1 is challenging. Nevertheless, it is crucial for treatment guiding and to determine the patient's prognosis. This study aimed to assess the interobserver variability in the histopathological evaluation of pT1 CRC.Methods and results A retrospective multicentre pT1 CRC cohort study was designed (EpiT1 consortium). A task force comprising 20 experienced pathologists conducted the histopathological evaluation using digitalized haematoxylin-eosin (H&E) slides. A pilot study was performed with 10 cases, and afterwards, a consensus meeting was held to assess interobserver variability. Then, a concordance study was performed by assessing 70 new pT1 CRC cases. We used percentage agreement and Gwet's Agreement Coefficient 1 for categorical variables, and intraclass correlation coefficient (ICC) for continuous variables. In the pilot study, histological grade and perineural invasion (PNI) demonstrated 100% agreement, with good concordance for lymphovascular invasion (LVI), tumour budding (TB), poorly differentiated clusters (PDC) and margin assessment. The concordance study showed high agreement (>= 90%) on histological grade, PDC, PNI and LVI. Submucosal invasion depth showed excellent reliability in the concordance study (ICC = 0.97). Notably, in both studies, the agreement of PDC was higher than for TB. Lower concordance was observed on stromal lymphocytes and the status of muscularis mucosae.Conclusions Our results emphasize the need for standardization in evaluating pT1 CRC to improve the concordance among pathologists, and the precision of digital measurements. Moreover, the addition of PDC assessment in pT1 CRC diagnostic guidelines could help to improve the accuracy of risk stratification and reliably predict prognosis.
Filiaciones:
de Gordoa, KS:
Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Dept Clin Fdn, Barcelona, Spain
Daca-Alvarez, M:
Hosp Clin Barcelona, Gastroenterol Dept, Barcelona, Spain
Archilla, I:
Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Dept Clin Fdn, Barcelona, Spain
Lopez-Prades, S:
Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Dept Clin Fdn, Barcelona, Spain
Aguirre, JJ:
Hosp Univ Araba, Pathol Dept, Vitoria, Spain
Bioaraba HRI, Vitoria, Spain
Alarcon-Molero, L:
Hosp Gen Valdepenas, Pathol Dept, Ciudad Real, Spain
Jurado, MC:
Hosp Univ 12 Octubre, Pathol Dept, Madrid, Spain
Canosa, A:
Hosp Univ La Ribera, Pathol Dept, Alzira, Spain
Giner, F:
Hosp Univ & Politecn La Fe, Pathol Dept, Valencia, Spain
Univ Valencia, Valencia, Spain
González-Lois, C:
Hosp Univ Puerta Hierro, Pathol Dept, Majadahonda, Spain
:
Hosp Badalona Germans Trias & Pujol, Pathol Dept, Badalona, Spain
Inst Germans Trias & Pujol, Badalona, Spain
Jurado, I:
Hosp Univ Consorsi Sanitari Terrassa, Pathol Dept, Terrassa, Spain
Machado, I:
Inst Valenciano Oncol, Pathol Dept, Valencia, Spain
Hosp QuironSalud, Pathol Lab, Valencia, Spain
Martínez-Ciarpaglini, C:
Univ Valencia, Valencia, Spain
Hosp Clin Univ Valencia, Pathol Dept, Valencia, Spain
Biomed Res Inst INCLIVA, Valencia, Spain
:
Hosp Univ Gen Catalunya, Pathol Dept, Grp QuironSalud, Sant Cugat Del Valles, Spain
Josep Carreras Leukaemia Res Inst IJC, Canc Epigenet Grp, Badalona, Spain
Naranjo, D:
Hosp Mar, Pathol Dept, Barcelona, Spain
Papaleo, N:
Corporacio Sanitaria Parc Tauli, Pathol Dept, Sabadell, Spain
Peña, C:
Complejo Hosp Univ, Pathol Dept, Albacete, Spain
Rosiñol, O:
Althaia Xarxa Assistencial Univ, Pathol Dept, Manresa, Spain
Sánchez-Yuste, R:
Hosp Univ Puerta Hierro, Pathol Dept, Majadahonda, Spain
Benítez, GTV:
Hosp Univ Puerta Hierro, Pathol Dept, Majadahonda, Spain
Pellisé, M:
Univ Barcelona, Dept Med, Barcelona, Spain
Hosp Clin Barcelona, Gastroenterol Dept, Barcelona, Spain
Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
Cuatrecasas, M:
Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain
Inst Invest Biomed August Pi I Sunyer IDIBAPS, Barcelona, Spain
Univ Barcelona, Dept Clin Fdn, Barcelona, Spain
Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
Green Submitted, hybrid
|